Cited by 246Immune Response and InflammationNF-κB Signaling PathwaysTuberculosis Research and Epidemiology

Role of Toll-Like Receptors in Changes in Gene Expression and NF-κB Activation in Mouse Hepatocytes Stimulated with Lipopolysaccharide

Open access
Liu, Shubing, Gallo, David J., Green, Angela M., Williams, Debra L., Gong, Xiaoyan, Shapiro, Richard A., Gambotto, Andrea A., Humphris, Elisabeth L. +2 more·2002·Infection and Immunity

Abstract

The liver is an important site of host-microbe interaction. Although hepatocytes have been reported to be responsive to lipopolysaccharide (LPS), the global gene expression changes by LPS and mechanism(s) by which LPS stimulates cultured hepatocytes remain uncertain. Cultures of primary mouse hepatocytes were incubated with LPS to assess its effects on the global gene expression, hepatic transcription factors, and mitogen-activated protein (MAP) kinase activation. DNA microarray analysis indicated that LPS modulates the selective expression of more than 80 genes and expressed sequence tags. We have shown previously that hepatocytes express CD14, which is required both for uptake and responsiveness to LPS. In other cells, responsiveness to microbial products requires expression of Toll-like receptors (TLR) and their associated accessory molecules. Hepatocytes expressed TLR1 through TLR9 as well as MyD88 and MD-2 transcripts, as shown by reverse transcriptase PCR analysis, indicating that hepatocytes express all known microbe recognition molecules. The MAP kinase extracellular signal-regulated kinase 1/2 was phosphorylated in response to LPS in mouse hepatocytes, and the levels of phosphorylation were lower in hepatocytes from TLR4-null mice. NF-kappa B activation was reduced in TLR4-mutant or -null hepatocytes compared to control hepatocytes, and this defect was partially restored by adenoviral transduction of mouse TLR4. Thus, hepatocytes respond to nanogram concentrations of…

Integrity signals

Registry

Crossref · 10.1128/iai.70.7.3433-3442.2002

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hepatocytes have been shown to produce other cytokines in response to LPS treatment.

    “Furthermore, although production of IL-6 by hepatocytes has not specifically been demonstrated, hepatocytes have been shown to produce other cytokines in response to LPS treatment [9].”
  • Hepatocytes have toll-like receptors that allow NFκB signaling to be invoked after stimulation with LPS.

    “As hepatocytes have toll-like receptors that allow NFκB signaling to be invoked after stimulation with LPS [9]”

The citation lists haven’t been fetched yet

References 61 · Cited by 246

Authors
Liu, S., Gallo, D. J., Green, A. M., Williams, D. L., Gong, X., Shapiro, R. A., Gambotto, A. A., Humphris, E. L., Vodovotz, Y., & Billiar, T. R.
Affiliations
  • University of Pittsburgh (US)
  • Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
Corresponding author
Liu, Shubing
Venue
Infection and Immunity
Published
2002-07
Volume
70
Issue
7
Pages
3433-3442
ISSN
  • 0019-9567 (ISSN-L)
  • 1098-5522
OpenAlex
W1970853163
Cited by
246
References
61
Citations by year
2026: 2 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 21 · 2020: 8 · 2019: 3 · 2018: 8 · 2017: 12 · 2016: 8 · 2015: 9 · 2014: 11 · 2013: 12 · 2012: 6
FWCI
3.61
Type
journal article
Language
en
Open access
Locations
  • Infection and Immunity (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Pittsburgh
  • National Institutes of Health
  • National Institute of General Medical Sciences (R01-GM-05441)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Keywords
Toll-like receptors, lipopolysaccharide, hepatocytes, NF-κB activation, gene expression, TLR4, MyD88, MD-2, MAPK signaling, ERK1/2 phosphorylation, CD14, host-microbe interactions
MeSH terms
Adenoviridae, Animals, Antigens, Differentiation, Antigens, Surface, Cells, Cultured, Genetic Vectors, Humans, Lipopolysaccharides, Membrane Glycoproteins, Mice, Inbred C3H, Mice, Inbred C57BL, Receptors, Cell Surface, Receptors, Immunologic, Tumor Cells, Cultured, Signal Transduction, Gene Expression, NF-kappa B, Transcription Factor AP-1, Mitogen-Activated Protein Kinase 1, Oligonucleotide Array Sequence Analysis, Mitogen-Activated Protein Kinases, Hepatocytes, Drosophila Proteins, Mitogen-Activated Protein Kinase 3, Adaptor Proteins, Signal Transducing, Toll-Like Receptors, Toll-Like Receptor 1, Toll-Like Receptor 4, Toll-Like Receptor 9, Lymphocyte Antigen 96, Mice, Myeloid Differentiation Factor 88

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review